Measles susceptibility in children in Karachi, Pakistan

Vaccine

Volumn 29, Issue 18, 2011, Pages 3419-3423

  Sheikh, Sana ^a   Ali, Asad ^a   Zaidi, Anita K M ^a   Agha, Ajmal ^a   Khowaja, Asif ^a   Allana, Salim ^a   Qureshi, Shahida ^a   Azam, Iqbal ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Measles; Pakistan; Seroprevalence; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MEASLES; MEASLES VACCINATION; PAKISTAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SALIVA ANALYSIS; SEROPREVALENCE; VIRUS IMMUNITY;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INFANT; MALE; MEASLES; MEASLES VACCINE; PAKISTAN; SEROEPIDEMIOLOGIC STUDIES;

EID: 79954667359     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.087     Document Type: Article

References (29)

1. Coverage RV, Coverage SV. Progress toward measles elimination-Eastern Mediterranean Region; 1980-1998.
2. Gaafar T., Moshni E., Lievano F. The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010. The Journal of Infectious Diseases 2003, 187:S164-S171.
3. Progress towards reducing measles mortality and eliminating measles, WHO Eastern Mediterranean Region, 1997-2007. Weekly epidemiological record. 2008; 83(11):97-104.
4. Global measles deaths drop by 74%. Joint News Release WHO/UNICEF/American Red Cross/CDC/UN Foundation; 04 December 2008. Available from: [accessed 08.09.10]. http://www.who.int/mediacentre/news/releases/2008/pr47/en/index.html.
5. Immunization profile-Pakistan; 2009. Available from: http://www.apps.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm?C='pak' [accessed 01.06.10; 23.07.10].
6. Helfand R.F., Perry R., Strebel P. Vaccines must be given in order to protect. The Journal of Infectious Diseases 2007, 196:333-335.
7. Eradication C. Recommendations from a Meeting Cosponsored by the World Health organization, the Pan American Health organization, and CDC. MMWR 1997, 46:12-14.
8. Pakistan demographic and health survey 2006-07; 2010. Available from: [accessed 23.07.10]. http://www.measuredhs.com/pubs/pdf/FR200/FR200.pdf.
9. Strengthening immunization services through measles control, Phase IX. WHO/UNICEF; 2010, Available from: [accessed 25.07.10]. http://www.measlesinitiative.org/mi-files/Reports/Measles%2520Initiative/Annual%2520Reports/REVISED%2520FINAL%2520Measles%2520AR%25202008.pdf.
10. Karachi; 2009. Available from: http://cdgk/hometowns/tabid/72/Default.aspx [accessed 18.03.09].
11. Hong R., Banta J.E. Effects of extra immunization efforts on routine immunization at district level in Pakistan. Eastern Mediterranean Health Journal 2005, 11(4):745-752.
12. Vyse A.J., Cohen B.J., Ramsay M.E. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001, 115(3):201-207.
13. Nokes D.J., Enquselassie F., Vyse A., Nigatu W., Cutts F.T., Brown D.W.G. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Transactions of the Royal Society of Tropical Medicine and Hygiene 1998, 92(6):679-685.
14. Nokes D.J., Enquselassie F., Nigatu W., Vyse A.J., Cohen B.J., Brown D.W.G., et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bulletin of the World Health Organization 2001, 79:588-595.
15. Lowther S.A., Curriero F.C., Kalish B.T., Shields T.M., Monze M., Moss W.J. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. The Lancet 2009, 373(9668):1025-1032.
16. Measles IgG capture assay. Microimmune limited. Available from: [accessed 23.07.10]. http://www.microimmune.co.uk/new/measles_IgG_cap.htm.
17. Immunization coverage cluster survey-reference manual: immunization, vaccines and biologicals. World Health Organization. Available from: [accessed 23.07.10]. http://www.who.int/vaccines-documents/DocsPDF05/www767.pdf.
18. Maletta H. Weighting; 2006.
19. Immunization R, Activities SI. Progress toward measles mortality reduction and elimination-Eastern Mediterranean Region; 1997-2007.
20. Langsten R., Hill K. The accuracy of mothers' reports of child vaccination: evidence from rural Egypt1. Social Science & Medicine 1998, 46(9):1205-1212.
21. Ramakrishnan R., Venkata Rao T., Sundaramoorthy L., Joshua V. Magnitude of recall bias in the estimation of immunization coverage and its determinants. Indian Pediatrics 1999, 36:881-886.
22. Yekta Z., Porali R., Taravati M.R., Salary S., Khalily F., Shahabi S. Measles IgG sero-prevalence and its attributable factors in 5-25-year-old cases prior mass vaccination campaign in Urmia, northeastern Iran. IRCMJ 2007, 9(1):28-35.
23. Egemen A., Aksit S., Ozacar T., Kurugol Z., Keskinoglu P., Pehlivan T., et al. Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey. Pediatrics International 2001, 43(4):379-384.
24. Tayil S.E., El-Shazly M.K., El-Amrawy S.M., Ghouneim F.M., Abou Khatwa S.A., Masoud G.M. Sero-epidemiological study of measles after 15years of compulsory vaccination in Alexandria, Egypt. Eastern Mediterranean Health Journal 1998, 4(3):437-447.
25. Torun S.D., Bak rc N. Vaccination coverage and reasons for non-vaccination in a district of Istanbul. BMC Public Health 2006, 6(1):125.
26. Belmaker I., Bazarsky E., Dukhan L., Shlomo C., Rager-Zisman B. Two-dose measles immunization as a strategy to eliminate measles in the Middle East and Israel. The Israel Medical Association journal: IMAJ. 2008, 10(8-9):640.
27. Nigatu W., Nokes D.J., Cohen B.J., Brown D.W.G., Vyse A.J. Pre-and post-vaccine measles antibody status in infants using serum and oral-fluid testing: an evaluation of routine immunization in Addis Ababa, Ethiopia. Ethiopian Journal of Health Development 2004, 17(3):149.
28. Nigatu W., Samuel D., Cohen B., Cumberland P., Lemma E., Brown D.W.G., et al. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine 2008, 26(37):4769-4774.
29. Jani J.V., Holm-Hansen C., Mussá T., Zango A., Manhiça I., Bjune G., et al. Assessment of measles immunity among infants in Maputo City, Mozambique. BMC Public Health 2008, 8(1):386.